Navigation Links
Modulating the immune system to combat metastatic cancer
Date:5/24/2013

Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ignore cancer cells. Regulatory T cells are immune cells that function to suppress the immune system response. In this issue of the Journal of Clinical Investigation, researchers led by Ronald Levy at Stanford University found that regulatory T cells that infiltrate tumors express proteins that can be targeted with therapeutic antibodies. Mice injected with antibodies targeting the proteins CTLA-4 and OX-40 had smaller tumors and improved survival. Moreover, treatment with these antibodies cleared both tumors at the primary site and distant metastases, including brain metastases that are usually difficult to treat. These findings suggest that therapies targeting regulatory T cells could be a promising approach in cancer treatment. In an accompanying commentary, Cristina Ghirelli and Thorsten Hagemann emphasize that in order for this approach to be clinically relevant, it will be important to show that targeting regulatory T cells in metastatic tumors also blocks growth.


'/>"/>

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related biology news :

1. Portion of hippocampus found to play role in modulating anxiety
2. U of Alberta researcher steps closer to understand autoimmune diseases
3. UCI-led study uncovers how Salmonella avoids the bodys immune response
4. New insight into mechanisms behind autoimmune diseases suggests a potential therapy
5. Immune system implicated in prematurity complication
6. Key to immune system disease could lie inside the cheek
7. New immune defense enzyme discovered
8. New genetic mechanism of immune deficiency discovered
9. Carnegie Mellon fluorescent biosensor reveals mechanism critical to immune system amplification
10. Immune-response genes affecting breast tumor eradication
11. New screening technique yields elusive compounds to block immune-regulating enzyme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2020)... , ... June 23, 2020 , ... In its June ... interview with Dr. James L. Sherley, M.D., Ph.D., founder and director of stem ... company announced on June 16 that starting July 5 it would begin ...
(Date:6/19/2020)... , ... June 18, 2020 , ... Join experts from ... PhD, Principal Scientist in a live webinar on Wednesday, July 8, 2020 ... simplified the way we genetically engineer new models. However, while modifying the genome may ...
(Date:6/11/2020)... N.H. (PRWEB) , ... June 09, 2020 , ... ... of custom industrial automation and IT solutions for the life sciences industry, is pleased ... of Business Development working out of the company’s Seabrook, New Hampshire office. In ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products has introduced ... materials for use with CRM, neurostimulation, vascular, and related devices. , Anomet ... design requirements, performance, and cost criteria; especially where solid wire is limited. Typical ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... top radiation centers in 16 countries, has reached its 20th anniversary of worldwide ... in routine use at top universities including University of Pennsylvania, University of Michigan, ...
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and catheter ... great surgery is only the beginning of a successful study, while protecting and accessing ... Brad Gien, Global Head of Surgery from Envigo in a live ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , a ... and food industries, is pleased to announce that Charles Galea has joined its ... , Charles is an accomplished and results-driven sales executive with over 10 years ...
Breaking Biology Technology: